Selected research
Industry Research
Desloratadine Oral Solution Industry Research Report 2026
Market perspective
The global Desloratadine Oral Solution market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Desloratadine Oral Solution is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Desloratadine Oral Solution is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Desloratadine Oral Solution is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Desloratadine Oral Solution include Yabao Pharmaceutical, SHIJIAZHUANG HUAXIN PHARMACEUTICAL, Shandong Langnuo Pharmaceutical, Merck Sharp & Dohme, Huluwa Pharmaceutical, Hefei Amvite Pharmaceutical, Harbin Sanctity Biological Pharmaceutical, Sinopharm Zhijun and Beimei Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Desloratadine Oral Solution market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Desloratadine Oral Solution Market by Company
Yabao Pharmaceutical
SHIJIAZHUANG HUAXIN PHARMACEUTICAL
Shandong Langnuo Pharmaceutical
Merck Sharp & Dohme
Huluwa Pharmaceutical
Hefei Amvite Pharmaceutical
Harbin Sanctity Biological Pharmaceutical
Sinopharm Zhijun
Beimei Pharmaceutical
Avanc Pharma
Anhui Xinshiji Pharmaceutical
Desloratadine Oral Solution Segment by Type
0.5mg/ml
0.25mg/ml
Desloratadine Oral Solution Segment by Application
Hospital
Clinic
Pharmacy
Desloratadine Oral Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Desloratadine Oral Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Desloratadine Oral Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Desloratadine Oral Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Desloratadine Oral Solution manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Desloratadine Oral Solution by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Desloratadine Oral Solution in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.5mg/ml
- 0.25mg/ml
Applications
- Hospital
- Clinic
- Pharmacy
Companies covered
- Yabao Pharmaceutical
- SHIJIAZHUANG HUAXIN PHARMACEUTICAL
- Shandong Langnuo Pharmaceutical
- Merck Sharp & Dohme
- Huluwa Pharmaceutical
- Hefei Amvite Pharmaceutical
- Harbin Sanctity Biological Pharmaceutical
- Sinopharm Zhijun
- Beimei Pharmaceutical
- Avanc Pharma
- Anhui Xinshiji Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Desloratadine Oral Solution Market Size (2021-2032)
- 2.2.2 Global Desloratadine Oral Solution Sales (2021-2032)
- 2.2.3 Global Desloratadine Oral Solution Market Average Price (2021-2032)
- 2.3 Desloratadine Oral Solution by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 0.5mg/ml
- 2.3.3 0.25mg/ml
- 2.4 Desloratadine Oral Solution by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Desloratadine Oral Solution Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Desloratadine Oral Solution Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Desloratadine Oral Solution Revenue of Manufacturers (2021-2026)
- 3.4 Global Desloratadine Oral Solution Average Price by Manufacturers (2021-2026)
- 3.5 Global Desloratadine Oral Solution Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Desloratadine Oral Solution, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Desloratadine Oral Solution, Product Type & Application
- 3.8 Global Manufacturers of Desloratadine Oral Solution, Established Date
- 3.9 Global Desloratadine Oral Solution Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Yabao Pharmaceutical
- 4.1.1 Yabao Pharmaceutical Company Information
- 4.1.2 Yabao Pharmaceutical Business Overview
- 4.1.3 Yabao Pharmaceutical Desloratadine Oral Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Yabao Pharmaceutical Desloratadine Oral Solution Product Portfolio
- 4.1.5 Yabao Pharmaceutical Recent Developments
- 4.2 SHIJIAZHUANG HUAXIN PHARMACEUTICAL
- 4.2.1 SHIJIAZHUANG HUAXIN PHARMACEUTICAL Company Information
- 4.2.2 SHIJIAZHUANG HUAXIN PHARMACEUTICAL Business Overview
- 4.2.3 SHIJIAZHUANG HUAXIN PHARMACEUTICAL Desloratadine Oral Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 SHIJIAZHUANG HUAXIN PHARMACEUTICAL Desloratadine Oral Solution Product Portfolio
- 4.2.5 SHIJIAZHUANG HUAXIN PHARMACEUTICAL Recent Developments
- 4.3 Shandong Langnuo Pharmaceutical
- 4.3.1 Shandong Langnuo Pharmaceutical Company Information
- 4.3.2 Shandong Langnuo Pharmaceutical Business Overview
- 4.3.3 Shandong Langnuo Pharmaceutical Desloratadine Oral Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shandong Langnuo Pharmaceutical Desloratadine Oral Solution Product Portfolio
- 4.3.5 Shandong Langnuo Pharmaceutical Recent Developments
- 4.4 Merck Sharp & Dohme
- 4.4.1 Merck Sharp & Dohme Company Information
- 4.4.2 Merck Sharp & Dohme Business Overview
- 4.4.3 Merck Sharp & Dohme Desloratadine Oral Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Merck Sharp & Dohme Desloratadine Oral Solution Product Portfolio
- 4.4.5 Merck Sharp & Dohme Recent Developments
- 4.5 Huluwa Pharmaceutical
- 4.5.1 Huluwa Pharmaceutical Company Information
- 4.5.2 Huluwa Pharmaceutical Business Overview
- 4.5.3 Huluwa Pharmaceutical Desloratadine Oral Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Huluwa Pharmaceutical Desloratadine Oral Solution Product Portfolio
- 4.5.5 Huluwa Pharmaceutical Recent Developments
- 4.6 Hefei Amvite Pharmaceutical
- 4.6.1 Hefei Amvite Pharmaceutical Company Information
- 4.6.2 Hefei Amvite Pharmaceutical Business Overview
- 4.6.3 Hefei Amvite Pharmaceutical Desloratadine Oral Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Hefei Amvite Pharmaceutical Desloratadine Oral Solution Product Portfolio
- 4.6.5 Hefei Amvite Pharmaceutical Recent Developments
- 4.7 Harbin Sanctity Biological Pharmaceutical
- 4.7.1 Harbin Sanctity Biological Pharmaceutical Company Information
- 4.7.2 Harbin Sanctity Biological Pharmaceutical Business Overview
- 4.7.3 Harbin Sanctity Biological Pharmaceutical Desloratadine Oral Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Harbin Sanctity Biological Pharmaceutical Desloratadine Oral Solution Product Portfolio
- 4.7.5 Harbin Sanctity Biological Pharmaceutical Recent Developments
- 4.8 Sinopharm Zhijun
- 4.8.1 Sinopharm Zhijun Company Information
- 4.8.2 Sinopharm Zhijun Business Overview
- 4.8.3 Sinopharm Zhijun Desloratadine Oral Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sinopharm Zhijun Desloratadine Oral Solution Product Portfolio
- 4.8.5 Sinopharm Zhijun Recent Developments
- 4.9 Beimei Pharmaceutical
- 4.9.1 Beimei Pharmaceutical Company Information
- 4.9.2 Beimei Pharmaceutical Business Overview
- 4.9.3 Beimei Pharmaceutical Desloratadine Oral Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Beimei Pharmaceutical Desloratadine Oral Solution Product Portfolio
- 4.9.5 Beimei Pharmaceutical Recent Developments
- 4.10 Avanc Pharma
- 4.10.1 Avanc Pharma Company Information
- 4.10.2 Avanc Pharma Business Overview
- 4.10.3 Avanc Pharma Desloratadine Oral Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Avanc Pharma Desloratadine Oral Solution Product Portfolio
- 4.10.5 Avanc Pharma Recent Developments
- 4.11 Anhui Xinshiji Pharmaceutical
- 4.11.1 Anhui Xinshiji Pharmaceutical Company Information
- 4.11.2 Anhui Xinshiji Pharmaceutical Business Overview
- 4.11.3 Anhui Xinshiji Pharmaceutical Desloratadine Oral Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Anhui Xinshiji Pharmaceutical Desloratadine Oral Solution Product Portfolio
- 4.11.5 Anhui Xinshiji Pharmaceutical Recent Developments
5 Global Desloratadine Oral Solution Market Scenario by Region
- 5.1 Global Desloratadine Oral Solution Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Desloratadine Oral Solution Sales by Region: 2021-2032
- 5.2.1 Global Desloratadine Oral Solution Sales by Region: 2021-2026
- 5.2.2 Global Desloratadine Oral Solution Sales by Region: 2027-2032
- 5.3 Global Desloratadine Oral Solution Revenue by Region: 2021-2032
- 5.3.1 Global Desloratadine Oral Solution Revenue by Region: 2021-2026
- 5.3.2 Global Desloratadine Oral Solution Revenue by Region: 2027-2032
- 5.4 North America Desloratadine Oral Solution Market Facts & Figures by Country
- 5.4.1 North America Desloratadine Oral Solution Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Desloratadine Oral Solution Sales by Country (2021-2032)
- 5.4.3 North America Desloratadine Oral Solution Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Desloratadine Oral Solution Market Facts & Figures by Country
- 5.5.1 Europe Desloratadine Oral Solution Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Desloratadine Oral Solution Sales by Country (2021-2032)
- 5.5.3 Europe Desloratadine Oral Solution Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Desloratadine Oral Solution Market Facts & Figures by Country
- 5.6.1 Asia Pacific Desloratadine Oral Solution Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Desloratadine Oral Solution Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Desloratadine Oral Solution Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Desloratadine Oral Solution Market Facts & Figures by Country
- 5.7.1 South America Desloratadine Oral Solution Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Desloratadine Oral Solution Sales by Country (2021-2032)
- 5.7.3 South America Desloratadine Oral Solution Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Desloratadine Oral Solution Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Desloratadine Oral Solution Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Desloratadine Oral Solution Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Desloratadine Oral Solution Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Desloratadine Oral Solution Sales by Type (2021-2032)
- 6.1.1 Global Desloratadine Oral Solution Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Desloratadine Oral Solution Sales Market Share by Type (2021-2032)
- 6.2 Global Desloratadine Oral Solution Revenue by Type (2021-2032)
- 6.2.1 Global Desloratadine Oral Solution Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Desloratadine Oral Solution Revenue Market Share by Type (2021-2032)
- 6.3 Global Desloratadine Oral Solution Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Desloratadine Oral Solution Sales by Application (2021-2032)
- 7.1.1 Global Desloratadine Oral Solution Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Desloratadine Oral Solution Sales Market Share by Application (2021-2032)
- 7.2 Global Desloratadine Oral Solution Revenue by Application (2021-2032)
- 7.2.1 Global Desloratadine Oral Solution Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Desloratadine Oral Solution Revenue Market Share by Application (2021-2032)
- 7.3 Global Desloratadine Oral Solution Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Desloratadine Oral Solution Value Chain Analysis
- 8.1.1 Desloratadine Oral Solution Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Desloratadine Oral Solution Production Mode & Process
- 8.2 Desloratadine Oral Solution Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Desloratadine Oral Solution Distributors
- 8.2.3 Desloratadine Oral Solution Customers
9 Global Desloratadine Oral Solution Analyzing Market Dynamics
- 9.1 Desloratadine Oral Solution Industry Trends
- 9.2 Desloratadine Oral Solution Industry Drivers
- 9.3 Desloratadine Oral Solution Industry Opportunities and Challenges
- 9.4 Desloratadine Oral Solution Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst